Current Status of Dendritic Cell-Based Tumor Vaccination

Publisher： Karger

E-ISSN： 2296-5262|23|6|544-551

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.6, 2001-01, pp. : 544-551

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dendritic Cell-Based Immunoregulatory Strategies

By  

International Archives of Allergy and Immunology, Vol. 127, Iss. 4, 2002-05 ,pp. : 251-258

Karger

Access to resources Recommend Favorite

Dendritic Cell-Based Immunotherapy of Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 61, Iss. 2, 1999-01 ,pp. : 67-71

Karger

Access to resources Recommend Favorite

Cell-based vaccination against melanoma – background, preliminary results, and perspective

By Sun Yuansheng   Paschen Annette   Schadendorf Dirk  

Journal of Molecular Medicine, Vol. 77, Iss. 8, 1999-08 ,pp. : 593-608

Springer Publishing Company

Access to resources Recommend Favorite

New Technologies toward Dendritic Cell‐Based Cancer Immunotherapies

By  

THE JOURNAL OF DERMATOLOGY, Vol. 26, Iss. 11, 1999-11 ,pp. : 757-763

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Status and Perspectives of Stem Cell Based Therapies for Liver Diseases

By  

Recent Patents on Regenerative Medicine, Vol. 1, Iss. 3, 2011-09 ,pp. : 299-305

Bentham Science Publishers

Access to resources Recommend Favorite